Lic Mf Healthcare Fund
LIC Mutual Fund Β· FM: Sudhanshu Asthana Β· INF397L01LK4 Β· Direct
NAV βΉ37.96 AUM βΉ93 Cr as of 22 Sep 2026
Latest available portfolio Β· Retrieved: 8-Aug-2026 11:47 PM IST Β· Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.5% | +1.3% | +9.3% | +26.3% | +16.6% | +23.7% | β | 31/234 | 1.37% |
Equity allocation
95.21%
Non-equity allocation (combined)
4.79%
All Equity Holdings (23) latest available
| # | Company | Value (βΉ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 9.8 | 10.55% | β |
| 2 | Divi's Laboratories Ltd | 6.6 | 7.17% | β |
| 3 | Apollo Hospitals Enterprise Ltd | 6.3 | 6.77% | β |
| 4 | Torrent Pharmaceuticals Ltd | 6.1 | 6.55% | β |
| 5 | Neuland Laboratories Ltd | 5.3 | 5.74% | β |
| 6 | Navin Fluorine International Ltd | 5.2 | 5.58% | β |
| 7 | Aurobindo Pharma Ltd | 4.9 | 5.30% | β |
| 8 | Zydus Lifesciences Ltd | 4.7 | 5.11% | β |
| 9 | Fortis Healthcare Ltd | 4.1 | 4.45% | β |
| 10 | Gland Pharma Ltd | 3.5 | 3.79% | β |
| 11 | Aster DM Quality Care Ltd Ordinary Shares | 2.9 | 3.18% | β |
| 12 | Global Health Ltd | 2.9 | 3.16% | β |
| 13 | Ipca Laboratories Ltd | 2.8 | 3.05% | β |
| 14 | Biocon Ltd | 2.7 | 2.87% | β |
| 15 | Glenmark Pharmaceuticals Ltd | 2.6 | 2.86% | β |
| 16 | Metropolis Healthcare Ltd | 2.6 | 2.76% | β |
| 17 | Artemis Medicare Services Ltd Ordinary Shares | 2.5 | 2.68% | β |
| 18 | OneSource Specialty Pharma Ltd | 2.5 | 2.67% | β |
| 19 | Acutaas Chemicals Ltd | 2.2 | 2.40% | β |
| 20 | Mankind Pharma Ltd | 2.2 | 2.36% | β |
| 21 | Anthem Biosciences Ltd | 1.9 | 2.11% | β |
| 22 | Dr Agarwalβs Health Care Ltd | 1.9 | 2.05% | β |
| 23 | Max Healthcare Institute Ltd Ordinary Shares | 1.9 | 2.05% | β |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.